Katherine Matthay, MD

Attending Physician
Pediatric Hematology/Oncology
[email protected]
+1 415 476-3831

Dr. Katherine Matthay is the chief of Pediatric Hematology-Oncology at UCSF Benioff Children's Hospital and has been focused for more than 20 years on translational research in neuroblastoma, a deadly childhood cancer. At UCSF, she has developed and led multiple trials using a unique targeted radiopharmaceutical, 131I-MIBG for neuroblastoma.

Dr. Matthay also leads the UCSF Pediatric Malignancies Program and an NIH funded Phase I New Approaches to Neuroblastoma Therapy consortium (NANT) for treatment of relapsed and resistant neuroblastoma.

Publications: 

Editor's Note: Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma.

Cancer research

Chesler L, Schlieve C, Goldenberg DD, Kenney A, Kim G, McMillan A, Matthay KK, Rowitch D, Weiss WA

Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma.

EJNMMI research

Kumar P, Koach J, Nekritz E, Mukherjee S, Braun BS, DuBois SG, Nasholm N, Haas-Kogan D, Matthay KK, Weiss WA, Gustafson C, Seo Y

Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

Pediatric blood & cancer

Barr EK, Naranjo A, Twist CJ, Tenney SC, Schmidt ML, London WB, Gastier-Foster J, Adkins ES, Mattei P, Handler MH, Matthay KK, Park JR, Maris JM, Desai AV, Cohn SL

ALK upregulates POSTN and WNT signaling to drive neuroblastoma.

Cell reports

Huang M, Fang W, Farrel A, Li L, Chronopoulos A, Nasholm N, Cheng B, Zheng T, Yoda H, Barata MJ, Porras T, Miller ML, Zhen Q, Ghiglieri L, McHenry L, Wang L, Asgharzadeh S, Park J, Gustafson WC, Matthay KK, Maris JM, Weiss WA

Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma.

Research square

Kumar P, Koach J, Nekritz E, Mukherjee S, Braun BS, DuBois SG, Nasholm N, Haas-Kogan D, Matthay KK, Weiss WA, Gustafson C, Seo Y

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.

British journal of cancer

Hogarty MD, Ziegler DS, Franson A, Chi YY, Tsao-Wei D, Liu K, Vemu R, Gerner EW, Bruckheimer E, Shamirian A, Hasenauer B, Balis FM, Groshen S, Norris MD, Haber M, Park JR, Matthay KK, Marachelian A

Pediatric neuroblastoma with intraspinal extension: the role of surgical management.

Journal of neurosurgery. Pediatrics

Chang D, Oh T, Roland JL, Matthay KK, Vo KT, Edwards CS, Sun PP, Auguste KI, Gupta N

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.

Pediatric blood & cancer

Batra V, Gikandi A, Pawel B, Martinez D, Granger MM, Marachelian A, Park JR, Maris JM, Vo KT, Matthay KK, DuBois SG

Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.

Cell reports

Rosenberg MI, Greenstein E, Buchkovich M, Peres A, Santoni-Rugiu E, Yang L, Mikl M, Vaksman Z, Gibbs DL, Reshef D, Salovin A, Irwin MS, Naranjo A, Ulitsky I, de Alarcon PA, Matthay KK, Weigman V, Yaari G, Panzer JA, Friedman N, Maris JM

Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.

Pediatric blood & cancer

Streby KA, Parisi MT, Shulkin BL, LaBarre B, Bagatell R, Diller L, Grupp SA, Matthay KK, Voss SD, Yu AL, London WB, Park JR, Yanik GA, Naranjo A

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

Nature medicine

Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Moss? YP

Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma.

International journal of radiation oncology, biology, physics

Campbell K, Groshen S, Evans AC, Wilson S, Sebastian A, Loots GG, Marachelian A, Armant M, Pal S, Haas-Kogan DA, Park JR, Granger M, Matthay KK, Coleman MA, DuBois SG

Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.

Cancer

Park JR, Villablanca JG, Hero B, Kushner BH, Wheatley K, Beiske KH, Ladenstein RL, Baruchel S, Macy ME, Moreno L, Seibel NL, Pearson AD, Matthay KK, Valteau-Couanet D

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Desai AV, Gilman AL, Ozkaynak MF, Naranjo A, London WB, Tenney SC, Diccianni M, Hank JA, Parisi MT, Shulkin BL, Smith M, Moscow JA, Shimada H, Matthay KK, Cohn SL, Maris JM, Bagatell R, Sondel PM, Park JR, Yu AL

Advancing therapy for neuroblastoma.

Nature reviews. Clinical oncology

Qiu B, Matthay KK

Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Pediatric blood & cancer

Vo KT, DuBois SG, Neuhaus J, Braunstein SE, Weil BR, Naranjo A, Irtan S, Balaguer J, Matthay KK

Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I Exposures.

Radiation research

Evans AC, Setzkorn T, Edmondson DA, Segelke H, Wilson PF, Matthay KK, Granger MM, Marachelian A, Haas-Kogan DA, DuBois SG, Coleman MA

Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries.

Pediatric blood & cancer

Matthay KK, Hylton J, Penumarthy N, Khattab M, Soh SY, Nguyen HTK, Alcasabas AP, Fawzy M, Saab R, Khan MS, Ghandour K, Chantada G, Parikh NS, Faulkner L, Lam CG, Howard SC

Anatomic patterns of relapse and progression following treatment with 131 I-MIBG in relapsed or refractory neuroblastoma.

Pediatric blood & cancer

Fishel Ben Kenan R, Polishchuk AL, Hawkins RA, Braunstein SE, Matthay KK, DuBois SG, Haas-Kogan DA

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK

A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Pediatric blood & cancer

Weiss BD, Yanik G, Naranjo A, Zhang FF, Fitzgerald W, Shulkin BL, Parisi MT, Russell H, Grupp S, Pater L, Mattei P, Mosse Y, Lai HA, Jarzembowski JA, Shimada H, Villablanca JG, Giller R, Bagatell R, Park JR, Matthay KK

Long-term follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-risk Neuroblastoma: COG Study ANBL0032.

Clinical cancer research : an official journal of the American Association for Cancer Research

Yu AL, Gilman AL, Ozkaynak MF, Naranjo A, Diccianni MB, Gan J, Hank JA, Batova A, London WB, Tenney SC, Smith MA, Shulkin BL, Parisi MT, Matthay KK, Cohn SL, Maris JM, Bagatell R, Park JR, Sondel PM

Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.

Cancer medicine

Temple WC, Vo KT, Matthay KK, Balliu B, Coleman C, Michlitsch J, Phelps A, Behr S, Zapala MA

Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy.

Journal of pediatric hematology/oncology

Lavergne V, Sabnis A, Tupule A, Davidson PR, Kline C, Matthay K, Nicolaides T, Goldsby R, Braunstein S, Fogh SE, Sneed PK, Menzel P, Nakamura A, DuBois SG, Haas-Kogan DA, Nakamura JL

124I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Aboian M, Huang SY, Pampaloni MH, Hawkins RA, Huh Y, Vo K, Gustafson C, Matthay K, Seo Y

Differences in Genomic Profiles and Outcomes between Thoracic and Adrenal Neuroblastoma.

Journal of the National Cancer Institute

Oldridge DA, Truong B, Russ D, DuBois SG, Vaksman Z, Mosse YP, Diskin SJ, Maris JM, Matthay KK

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Chévez-Barrios P, Eagle RC, Krailo M, Piao J, Albert DM, Gao Y, Vemuganti G, Ali MJ, Khetan V, Honavar SG, O'Brien J, Leahey AM, Matthay K, Meadows A, Chintagumpala M

Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Twist CJ, Schmidt ML, Naranjo A, London WB, Tenney SC, Marachelian A, Shimada H, Collins MH, Esiashvili N, Adkins ES, Mattei P, Handler M, Katzenstein H, Attiyeh E, Hogarty MD, Gastier-Foster J, Wagner E, Matthay KK, Park JR, Maris JM, Cohn SL

Risk factors for transplant-associated thrombotic microangiopathy following autologous hematopoietic cell transplantation in high-risk neuroblastoma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.

Pediatric blood & cancer

Campbell K, Shyr D, Bagatell R, Fischer M, Nakagawara A, Nieto AC, Brodeur GM, Matthay KK, London WB, DuBois SG

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.

Pediatric blood & cancer

Braunstein SE, London WB, Kreissman SG, Villablanca JG, Davidoff AM, DeSantes K, Castleberry RP, Murray K, Diller L, Matthay K, Cohn SL, Shulkin B, von Allmen D, Parisi MT, Van Ryn C, Park JR, La Quaglia MP, Haas-Kogan DA

Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT.

Medical physics

Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Twist CJ, Naranjo A, Schmidt ML, Tenney SC, Cohn SL, Meany HJ, Mattei P, Adkins ES, Shimada H, London WB, Park JR, Matthay KK, Maris JM

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Dubois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith KC, Granger M, Weiss B, Park JR, Macy ME, Cohn SL, Yanik GA, Wagner LM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Boucher N, Czarnecki S, Luo C, Tsao-Wei D, Matthay KK, Marachelian A

Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives.

Cureus

Kumar P, Gill RM, Phelps A, Tulpule A, Matthay K, Nicolaides T

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Pediatric blood & cancer

Pinto N, DuBois SG, Marachelian A, Diede SJ, Taraseviciute A, Glade Bender JL, Tsao-Wei D, Groshen SG, Reid JM, Haas-Kogan DA, Reynolds CP, Kang MH, Irwin MS, Macy ME, Villablanca JG, Matthay KK, Park JR

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

Pediatric blood & cancer

Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK

Estimation of intra-arterial chemotherapy distribution to the retina in pediatric retinoblastoma patients using quantitative digital subtraction angiography.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

Kondapavulur S, Cooke DL, Kao A, Amans MR, Alexander M, Darflinger R, Dowd CF, Higashida RT, Damato B, Halbach VV, Matthay KK, Hetts SW

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

The lancet child & adolescent health

de Alarcon PA, Matthay KK, London WB, Naranjo A, Tenney SC, Panzer JA, Hogarty MD, Park JR, Maris JM, Cohn SL

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.

Clinical cancer research : an official journal of the American Association for Cancer Research

Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Gilman AL, Yu AL, Sondel PM

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.

European journal of nuclear medicine and molecular imaging

Ladenstein R, Lambert B, Pötschger U, Castellani MR, Lewington V, Bar-Sever Z, Oudoux A, Sliwinska A, Taborska K, Biassoni L, Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Nadel H, Gelfand MJ, Matthay KK, Park JR, Kreissman SG, Valteau-Couanet D, Boubaker A

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Yanik GA, Parisi MT, Naranjo A, Nadel H, Gelfand MJ, Park JR, Ladenstein RL, Poetschger U, Boubaker A, Valteau-Couanet D, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Kreissman SG, Shulkin BL, Matthay KK

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.

Cancer

Campbell K, Gastier-Foster JM, Mann M, Naranjo AH, Van Ryn C, Bagatell R, Matthay KK, London WB, Irwin MS, Shimada H, Granger MM, Hogarty MD, Park JR, DuBois SG

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.

Clinical cancer research : an official journal of the American Association for Cancer Research

Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss BD, Goldsmith K, Granger M, Matthay KK, Groshen S, Asgharzadeh S, Sposto R, Seeger RC

Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131I- Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma.

International journal of radiation oncology, biology, physics

Campbell K, Karski EE, Olow A, Edmondson DA, Kohlgruber AC, Coleman M, Haas-Kogan DA, Matthay KK, DuBois SG

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.

Pediatric blood & cancer

DuBois SG, Mody R, Naranjo A, Van Ryn C, Russ D, Oldridge D, Kreissman S, Baker DL, Parisi M, Shulkin BL, Bai H, Diskin SJ, Batra V, Maris JM, Park JR, Matthay KK, Yanik G

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.

Oncotarget

Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG

Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.

Journal of pediatric hematology/oncology

Dinh T, Truong B, Matthay KK, DuBois SG

Neuroblastoma.

Nature reviews. Disease primers

Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA

Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.

International journal of radiation oncology, biology, physics

Li R, Polishchuk A, DuBois S, Hawkins R, Lee SW, Bagatell R, Shusterman S, Hill-Kayser C, Al-Sayegh H, Diller L, Haas-Kogan DA, Matthay KK, London WB, Marcus KJ

Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.

European journal of cancer (Oxford, England : 1990)

Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK

Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.

Radiation research

Edmondson DA, Karski EE, Kohlgruber A, Koneru H, Matthay KK, Allen S, Hartmann CL, Peterson LE, DuBois SG, Coleman MA

Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.

European journal of cancer (Oxford, England : 1990)

Morgenstern DA, London WB, Stephens D, Volchenboum SL, Simon T, Nakagawara A, Shimada H, Schleiermacher G, Matthay KK, Cohn SL, Pearson AD, Irwin MS

Reply: Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

Pediatric blood & cancer

Lee JS, Matthay K, DuBois SG, Roy-Burman A

Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

European journal of nuclear medicine and molecular imaging

Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Parisi MT, Shulkin BL, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Pediatric blood & cancer

Villablanca JG, Volchenboum SL, Cho H, Kang MH, Cohn SL, Anderson CP, Marachelian A, Groshen S, Tsao-Wei D, Matthay KK, Maris JM, Hasenauer CE, Czarnecki S, Lai H, Goodarzian F, Shimada H, Reynolds CP

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

DuBois SG, Marachelian A, Fox E, Kudgus RA, Reid JM, Groshen S, Malvar J, Bagatell R, Wagner L, Maris JM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Matthay KK, Mosse YP

Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.

Clinical cancer research : an official journal of the American Association for Cancer Research

Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG

Physician Perspectives on Palliative Care for Children With Neuroblastoma: An International Context.

Pediatric blood & cancer

Balkin EM, Thompson D, Colson KE, Lam CG, Matthay KK

Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.

Pediatric blood & cancer

Cohler C, Jumanne S, Kaijage J, DuBois SG, Scanlan P, Matthay KK

Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).

Pediatric blood & cancer

Trieu M, DuBois SG, Pon E, Nardo L, Hawkins RA, Marachelian A, Twist CJ, Park JR, Matthay KK

Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

European journal of nuclear medicine and molecular imaging

Temple W, Mendelsohn L, Kim GE, Nekritz E, Gustafson WC, Lin L, Giacomini K, Naranjo A, Van Ryn C, Yanik GA, Kreissman SG, Hogarty M, Matthay KK, DuBois SG

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL

Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).

European journal of cancer (Oxford, England : 1990)

Zhou MJ, Doral MY, DuBois SG, Villablanca JG, Yanik GA, Matthay KK

Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

Pediatric blood & cancer

Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP

Patient-specific dosimetry using pretherapy [¹²4I]m-iodobenzylguanidine ([¹²4I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.

Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging

Huang SY, Bolch WE, Lee C, Van Brocklin HF, Pampaloni MH, Hawkins RA, Sznewajs A, DuBois SG, Matthay KK, Seo Y

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.

Pediatric blood & cancer

Parikh NS, Howard SC, Chantada G, Israels T, Khattab M, Alcasabas P, Lam CG, Faulkner L, Park JR, London WB, Matthay KK

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK

131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer CB, Czarnecki S, Katzenstein HM, Matthay KK

Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma.

British journal of cancer

DuBois SG, Allen S, Bent M, Hilton JF, Hollinger F, Hawkins R, Courtier J, Mosse YP, Matthay KK

Reply to N.-K.V. Cheung et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, London WB, Maris J, Adamson PC, Park JR

Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.

Sarcoma

Thampi S, Matthay KK, Boscardin WJ, Goldsby R, DuBois SG

Drugging MYCN through an allosteric transition in Aurora kinase A.

Cancer cell

Gustafson WC, Meyerowitz JG, Nekritz EA, Chen J, Benes C, Charron E, Simonds EF, Seeger R, Matthay KK, Hertz NT, Eilers M, Shokat KM, Weiss WA

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG

Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.

Pediatric blood & cancer

Meany HJ, London WB, Ambros PF, Matthay KK, Monclair T, Simon T, Garaventa A, Berthold F, Nakagawara A, Cohn SL, Pearson AD, Park JR

Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma.

International journal of radiation oncology, biology, physics

Polishchuk AL, Li R, Hill-Kayser C, Little A, Hawkins RA, Hamilton J, Lau M, Tran HC, Strahlendorf C, Lemons RS, Weinberg V, Matthay KK, DuBois SG, Marcus KJ, Bagatell R, Haas-Kogan DA

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

BMC research notes

Kang MH, Villablanca JG, Glade Bender JL, Matthay KK, Groshen S, Sposto R, Czarnecki S, Ames MM, Reynolds CP, Marachelian A, Maurer BJ

Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Morgenstern DA, London WB, Stephens D, Volchenboum SL, Hero B, Di Cataldo A, Nakagawara A, Shimada H, Ambros PF, Matthay KK, Cohn SL, Pearson AD, Irwin MS

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.

Pediatric blood & cancer

Mossé YP, Deyell RJ, Berthold F, Nagakawara A, Ambros PF, Monclair T, Cohn SL, Pearson AD, London WB, Matthay KK

Current treatment and outcome for childhood acute leukemia in Tanzania.

Pediatric blood & cancer

Kersten E, Scanlan P, Dubois SG, Matthay KK

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.

The Lancet. Oncology

Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, Laquaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG

Adverse impact of regional lymph node involvement in osteosarcoma.

European journal of cancer (Oxford, England : 1990)

Thampi S, Matthay KK, Goldsby R, DuBois SG

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Pediatric blood & cancer

Maurer BJ, Kang MH, Villablanca JG, Janeba J, Groshen S, Matthay KK, Sondel PM, Maris JM, Jackson HA, Goodarzian F, Shimada H, Czarnecki S, Hasenauer B, Reynolds CP, Marachelian A

Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution.

Clinical ophthalmology (Auckland, N.Z.)

Thampi S, Hetts SW, Cooke DL, Stewart PJ, Robbins E, Banerjee A, Dubois SG, Char D, Halbach V, Matthay K

Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).

Pediatric blood & cancer

Wong T, Matthay KK, Boscardin WJ, Hawkins RA, Brakeman PR, DuBois SG

131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

DuBois SG, Matthay KK

Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma.

Anticancer research

Mueller S, Bhargava S, Molinaro AM, Yang X, Kolkowitz I, Olow A, Wehmeijer N, Orbach S, Chen J, Matthay KK, Haas-Kogan DA

Infections in hospitalized children and young adults with acute leukemia in Morocco.

Pediatric blood & cancer

Depasse J, Caniza MA, Quessar A, Khattab M, Hessissen L, Ribeiro R, Cherkaoui S, Benchekroun S, Matthay KK

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Yanik GA, Parisi MT, Shulkin BL, Naranjo A, Kreissman SG, London WB, Villablanca JG, Maris JM, Park JR, Cohn SL, McGrady P, Matthay KK

Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Pediatric blood & cancer

Green DM, Kun LE, Matthay KK, Meadows AT, Meyer WH, Meyers PA, Spunt SL, Robison LL, Hudson MM

Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.

Clinical cancer research : an official journal of the American Association for Cancer Research

Matthay KK

Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.

Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging

Seo Y, Gustafson WC, Dannoon SF, Nekritz EA, Lee CL, Murphy ST, VanBrocklin HF, Hernandez-Pampaloni M, Haas-Kogan DA, Weiss WA, Matthay KK

131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.

Pediatric blood & cancer

French S, DuBois SG, Horn B, Granger M, Hawkins R, Pass A, Plummer E, Matthay K

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.

International journal of molecular imaging

Dubois SG, Geier E, Batra V, Yee SW, Neuhaus J, Segal M, Martinez D, Pawel B, Yanik G, Naranjo A, London WB, Kreissman S, Baker D, Attiyeh E, Hogarty MD, Maris JM, Giacomini K, Matthay KK

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

British journal of cancer

Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD

Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.

Cancer epidemiology

Karski EE, Matthay KK, Neuhaus JM, Goldsby RE, Dubois SG

Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, Hadjidaniel M, Liu CW, Metelitsa LS, Pique-Regi R, Wakamatsu P, Villablanca JG, Kreissman SG, Matthay KK, Shimada H, London WB, Sposto R, Seeger RC

Evaluation of plasma annexin V levels in children and young adults with solid tumors.

The International journal of biological markers

Applebaum MA, Sambrano E, Lee S, Goldsby R, Matthay KK, DuBois SG

Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich J

Promising therapeutic targets in neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Matthay KK, George RE, Yu AL

Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Porzig A, Matthay KK, Dubois S, Pampaloni M, Damon L, Hawkins R, Goldsby R, Hollinger F, Fitzgerald P

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

Pediatric blood & cancer

Marachelian A, Shimada H, Sano H, Jackson H, Stein J, Sposto R, Matthay KK, Baker D, Villablanca JG

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, Murray K, Lavey RS, Matthay KK, Castleberry R, Maris JM, Cohn SL

Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.

Clinical cancer research : an official journal of the American Association for Cancer Research

DuBois SG, Chesler L, Groshen S, Hawkins R, Goodarzian F, Shimada H, Yanik G, Tagen M, Stewart C, Mosse YP, Maris JM, Tsao-Wei D, Marachelian A, Villablanca JG, Matthay KK

Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.

Science translational medicine

Chanthery YH, Gustafson WC, Itsara M, Persson A, Hackett CS, Grimmer M, Charron E, Yakovenko S, Kim G, Matthay KK, Weiss WA

Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.

Pediatric blood & cancer

Sharib JM, Cyrus J, Horvai A, Gray Hazard FK, Neuhaus J, Matthay KK, Goldsby R, Marina N, DuBois SG

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.

European journal of cancer (Oxford, England : 1990)

Angelini P, London WB, Cohn SL, Pearson AD, Matthay KK, Monclair T, Ambros PF, Shimada H, Leuschner I, Peuchmaur M, Irwin MS, Baruchel S

Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Park JR, Scott JR, Stewart CF, London WB, Naranjo A, Santana VM, Shaw PJ, Cohn SL, Matthay KK

Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK

Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.

Pediatric blood & cancer

DuBois SG, Goldsby R, Segal M, Woo J, Copren K, Kane JP, Pullinger CR, Matthay KK, Witte J, Lessnick SL, Robison LL, Bhatia S, Strong LC

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

London WB, Castel V, Monclair T, Ambros PF, Pearson AD, Cohn SL, Berthold F, Nakagawara A, Ladenstein RL, Iehara T, Matthay KK

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.

Radiology

Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T

Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.

Cancer letters

Mueller S, Yang X, Sottero TL, Gragg A, Prasad G, Polley MY, Weiss WA, Matthay KK, Davidoff AM, DuBois SG, Haas-Kogan DA

Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.

Clinical cancer research : an official journal of the American Association for Cancer Research

More SS, Itsara M, Yang X, Geier EG, Tadano MK, Seo Y, Vanbrocklin HF, Weiss WA, Mueller S, Haas-Kogan DA, Dubois SG, Matthay KK, Giacomini KM

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Cancer chemotherapy and pharmacology

Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Cancer

Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG

Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Worch J, Cyrus J, Goldsby R, Matthay KK, Neuhaus J, DuBois SG

Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.

European journal of cancer (Oxford, England : 1990)

Moroz V, Machin D, Faldum A, Hero B, Iehara T, Mosseri V, Ladenstein R, De Bernardi B, Rubie H, Berthold F, Matthay KK, Monclair T, Ambros PF, Pearson AD, Cohn SL, London WB

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.

Pediatric blood & cancer

Russell HV, Groshen SG, Ara T, DeClerck YA, Hawkins R, Jackson HA, Daldrup-Link HE, Marachelian A, Skerjanec A, Park JR, Katzenstein H, Matthay KK, Blaney SM, Villablanca JG

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.

The New England journal of medicine

Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.

The New England journal of medicine

Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK

Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.

Pediatric blood & cancer

Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, Matthay KK

Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.

Medical physics

Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, Hawkins RA, Dannoon SF, VanBrocklin HF, Itsara M, Weiss WA, Yang X, Haas-Kogan DA, Matthay KK, Seo Y

Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

Baggott C, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper BA, Miaskowski C

Osteosarcoma in children 5 years of age or younger at initial diagnosis.

Pediatric blood & cancer

Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG

Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

London WB, Frantz CN, Campbell LA, Seeger RC, Brumback BA, Cohn SL, Matthay KK, Castleberry RP, Diller L

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

British journal of cancer

Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL

An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Baggott CR, Dodd M, Kennedy C, Marina N, Matthay KK, Cooper B, Miaskowski C

Ethnic and racial differences in patients with Ewing sarcoma.

Cancer

Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG

Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.

Pediatric blood & cancer

Dubois SG, Epling CL, Teague J, Matthay KK, Sinclair E

Neuroblastoma: biology and staging.

Current oncology reports

Mueller S, Matthay KK

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

Pediatric blood & cancer

Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H

Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy.

Pediatric radiology

Sutton EJ, Tong RT, Gillis AM, Henning TD, Weinberg VA, Boddington S, Haas-Kogan DA, Matthay K, Sha V, Gooding C, Coakley FV, Daldrup-Link H

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P

Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.

International journal of radiation oncology, biology, physics

Jabbari S, Andolino D, Weinberg V, Missett BT, Law J, Wara WM, O'Donnell RJ, Matthay KK, DuBois SG, Goldsby R, Haas-Kogan DA

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Quach A, Huberty J, Franc BL, Hawkins RA, Jackson H, Groshen S, Shusterman S, Yanik G, Veatch J, Brophy P, Villablanca JG, Maris JM

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Wagner LM, Villablanca JG, Stewart CF, Crews KR, Groshen S, Reynolds CP, Park JR, Maris JM, Hawkins RA, Daldrup-Link HE, Jackson HA, Matthay KK

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.

Pediatric blood & cancer

Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds CP, Matthay KK

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Gilman AL, Ozkaynak MF, Matthay KK, Krailo M, Yu AL, Gan J, Sternberg A, Hank JA, Seeger R, Reaman GH, Sondel PM

Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Taggart D, Dubois S, Matthay KK

Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD

Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.

Cancer chemotherapy and pharmacology

Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SL

Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.

Neoplasia (New York, N.Y.)

Chesler L, Goldenberg DD, Collins R, Grimmer M, Kim GE, Tihan T, Nguyen K, Yakovenko S, Matthay KK, Weiss WA

Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project.

Pediatric blood & cancer

Dubois SG, London WB, Zhang Y, Matthay KK, Monclair T, Ambros PF, Cohn SL, Pearson A, Diller L

Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.

European journal of nuclear medicine and molecular imaging

Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL

Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.

European journal of nuclear medicine and molecular imaging

Koral KF, Huberty JP, Frame B, Matthay KK, Maris JM, Regan D, Normolle D, Yanik GA

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.

Nuclear medicine and biology

DuBois SG, Matthay KK

Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells.

Journal of cellular biochemistry

Meyer GE, Chesler L, Liu D, Gable K, Maddux BA, Goldenberg DD, Youngren JF, Goldfine ID, Weiss WA, Matthay KK, Rosenthal SM

Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.

International journal of radiation oncology, biology, physics

Gillis AM, Sutton E, Dewitt KD, Matthay KK, Weinberg V, Fisch BM, Chan A, Gooding C, Daldrup-Link H, Wara WM, Farmer DL, Harrison MR, Haas-Kogan D

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Yanik G, Messina J, Quach A, Huberty J, Cheng SC, Veatch J, Goldsby R, Brophy P, Kersun LS, Hawkins RA, Maris JM

Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.

Pediatric blood & cancer

Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.

Journal of the National Cancer Institute

Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A, Seeger RC

Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

Cancer research

Chesler L, Schlieve C, Goldenberg DD, Kenney A, Kim G, McMillan A, Matthay KK, Rowitch D, Weiss WA

Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

Annals of the New York Academy of Sciences

Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

Cancer research

Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, Maris JM

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

European journal of cancer (Oxford, England : 1990)

Sano H, Bonadio J, Gerbing RB, London WB, Matthay KK, Lukens JN, Shimada H

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.

Clinical cancer research : an official journal of the American Association for Cancer Research

Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM

Chromosome 1p and 11q deletions and outcome in neuroblastoma.

The New England journal of medicine

Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM

The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.

Cancer letters

London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B

Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK

Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.

Pediatric blood & cancer

Howard JP, Maris JM, Kersun LS, Huberty JP, Cheng SC, Hawkins RA, Matthay KK

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Cancer

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

DuBois SG, Messina J, Maris JM, Huberty J, Glidden DV, Veatch J, Charron M, Hawkins R, Matthay KK

Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.

Journal of pediatric surgery

Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM

Visual attention in long-term survivors of leukemia receiving cranial radiation therapy.

Journal of the International Neuropsychological Society : JINS

Schatz J, Kramer JH, Ablin AR, Matthay KK

Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

Cancer

Peuchmaur M, d'Amore ES, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H

Online exclusive: behavioral adjustment of children and adolescents with cancer: teacher, parent, and self-report.

Oncology nursing forum

Moore IM, Challinor J, Pasvogel A, Matthay K, Hutter J, Kaemingk K

Retinoid therapy of high-risk neuroblastoma.

Cancer letters

Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ

High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.

Cancer

Rose B, Matthay KK, Price D, Huberty J, Klencke B, Norton JA, Fitzgerald PA

Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.

Cancer

Matthay KK, Brisse H, Couanet D, Couturier J, Bénard J, Mosseri V, Edeline V, Lumbroso J, Valteau-Couanet D, Michon J

Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, Valteau-Couanet D, Hartmann O, Michon J

Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma.

Journal of pediatric hematology/oncology

Weiss B, Vora A, Huberty J, Hawkins RA, Matthay KK

Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16).

Blood

McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Feusner J, Matthay K, Dahl G, Smith MT

Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.

International journal of radiation oncology, biology, physics

Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK

Development and testing of the School Competency Assessment Scale.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

Challinor J, Moore IK, Kramer R, Pasvogel A, Leung K, Amylon M, Hutter J, Matthay K

Daycare attendance and risk of childhood acute lymphoblastic leukaemia.

British journal of cancer

Ma X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL, Reynolds P

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Yanik GA, Levine JE, Matthay KK, Sisson JC, Shulkin BL, Shapiro B, Hubers D, Spalding S, Braun T, Ferrara JL, Hutchinson RJ

Pediatric acute blastic natural killer cell leukemia.

Leukemia & lymphoma

DuBois SG, Etzell JE, Matthay KK, Robbins E, Banerjee A

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Matthay KK, Panina C, Huberty J, Price D, Glidden DV, Tang HR, Hawkins RA, Veatch J, Hasegawa B

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Cancer

Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK

Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.

The Journal of pediatrics

Hayward K, Jeremy RJ, Jenkins S, Barkovich AJ, Gultekin SH, Kramer J, Crittenden M, Matthay KK

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

Medical and pediatric oncology

Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

Medical and pediatric oncology

Cooper R, Khakoo Y, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Nakagawa A, Shimada H

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.

International journal of cancer

Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, Feuerstein BG, Speleman F

Functional and clinical outcomes of limb-sparing therapy for pediatric extremity sarcomas.

International journal of radiation oncology, biology, physics

Bertucio CS, Wara WM, Matthay KK, Ablin AR, Johnston JO, O'Donnell RJ, Weinberg V, Haas-Kogan DA

Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis.

AJR. American journal of roentgenology

Kammen BF, Matthay KK, Pacharn P, Gerbing R, Brasch RC, Gooding CA

Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Tang HR, Da Silva AJ, Matthay KK, Price DC, Huberty JP, Hawkins RA, Hasegawa BH

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

Medical and pediatric oncology

Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM

Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study.

Journal of pediatric psychology

Espy KA, Moore IM, Kaufmann PM, Kramer JH, Matthay K, Hutter JJ

Comprehensive analysis of chromosome 1p deletions in neuroblastoma.

Medical and pediatric oncology

Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM

Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.

Archives of ophthalmology (Chicago, Ill. : 1960)

Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM

Loss of heterozygosity for chromosome 14q in neuroblastoma.

Medical and pediatric oncology

Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Seeger RC, Reynolds CP, Gallego R, Stram DO, Gerbing RB, Matthay KK

Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.

Medical and pediatric oncology

Goto H, Keshelava N, Matthay KK, Lukens JN, Gerbing RB, Stram DO, Seeger RC, Reynolds CP

Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.

Medical and pediatric oncology

Park JR, Slattery J, Gooley T, Hawkins D, Lindsley K, Villablanca JG, Matthay KK, Sanders JE

Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.

Medical and pediatric oncology

Choi LM, Kim NW, Zuo JJ, Gerbing R, Stram D, Lukens JN, Matthay KK, Seeger RC, Reynolds CP

Cognitive consequences and central nervous system injury following treatment for childhood leukemia.

Seminars in oncology nursing

Moore IM, Espy KA, Kaufmann P, Kramer J, Kaemingk K, Miketova P, Mollova N, Kaspar M, Pasvogel A, Schram K, Wara W, Hutter J, Matthay K

MYCN expression in neuroblastoma: A mixed message?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK

Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.

Cancer

Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H

Is adjuvant therapy ever warranted in localized neuroblastoma.

Journal of pediatric hematology/oncology

Matthay KK, Stram D

Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.

Journal of pediatric hematology/oncology

Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J

Intraoperative radiation therapy for high-risk pediatric neuroblastoma.

International journal of radiation oncology, biology, physics

Haas-Kogan DA, Fisch BM, Wara WM, Swift PS, Farmer DL, Harrison MR, Albanese C, Weinberg V, Matthay KK

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM

Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK

Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

The New England journal of medicine

Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

Oncogene

Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM

The International Neuroblastoma Pathology Classification (the Shimada system).

Cancer

Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP

Molecular biology of neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Maris JM, Matthay KK

Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

Journal of pediatric hematology/oncology

DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, Haase GM, Black CT, Perez C, Shimada H, Gerbing R, Stram DO, Matthay KK

Congenital leukemia: successful treatment of a newborn with t(5;11)(q31;q23).

Journal of pediatric hematology/oncology

Fernandez MC, Weiss B, Atwater S, Shannon K, Matthay KK

Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancer.

International journal of cancer. Supplement = Journal international du cancer. Supplement

Challinor JM, Miaskowski CA, Franck LS, Slaughter RE, Matthay KK, Kramer RF, Veatch JJ, Paul SM, Amylon MD, Moore IM

Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.

Medical and pediatric oncology

Goldberg SS, DeSantes K, Huberty JP, Price D, Hasegawa BH, Reynolds CP, Seeger RC, Hattner R, Matthay KK

Stage 4S neuroblastoma: what makes it special?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Perez C, Seeger RC, Brodeur GM, Shimada H, Atkinson JB, Black CT, Gerbing R, Haase GM, Stram DO, Swift P, Lukens JN

Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Ozkaynak MF, Matthay K, Cairo M, Harris RE, Feig S, Reynolds CP, Buckley J, Villablanca JG, Seeger RC

Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.

Hormone research

Loh K, Matthay KK, Hoover M, Bracho FA, Cortez AB, Conte FA, Albanese CT, Miller TR, Price DC, Flores AJ, Kaviani A, Shoback D

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin A, Reynolds CP, Seeger RC, Weinberg VK, Price D

Neuroblastoma: biology and therapy.

Oncology (Williston Park, N.Y.)

Matthay KK

Telomerase expression in primary neuroblastomas.

European journal of cancer (Oxford, England : 1990)

Reynolds CP, Zuo JJ, Kim NW, Wang H, Lukens JN, Matthay KK, Seeger RC

The International Neuroblastoma Risk Groups (INRG): a preliminary report.

European journal of cancer (Oxford, England : 1990)

Castleberry RP, Pritchard J, Ambros P, Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B, Dicks-Mireaux C, Frappaz D, Haase GM, Haber M, Jones DR, Joshi VV, Kaneko M, Kemshead JT, Kogner P, Lee RE, Matthay KK, Michon JM, Monclair R, Roald BR, Seeger RC, Shaw PJ, Shuster JJ

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.

Cancer

Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM

Neuroblastoma in adults and adolescents: an indolent course with poor survival.

Cancer

Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK

Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.

The American journal of pathology

Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG

Renal cell carcinoma after therapy for neuroblastoma.

AJR. American journal of roentgenology

Donnelly LF, Rencken IO, Shardell K, Matthay KK, Miller CR, Vartanian RK, Gooding CA

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Stram DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, Brodeur GM, Seeger RC

Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK

Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.

Medical and pediatric oncology

Lang P, Vahlensieck M, Matthay KK, Johnston JO, Rosenau W, Gooding CA, Genant HK

Toxicities of total-body irradiation for pediatric bone marrow transplantation.

International journal of radiation oncology, biology, physics

Chou RH, Wong GB, Kramer JH, Wara DW, Matthay KK, Crittenden MR, Swift PS, Cowan MJ, Wara WM

Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience.

Annals of surgical oncology

Haase GM, O'Leary MC, Stram DO, Lukens JN, Seeger RC, Shimada H, Matthay KK

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.

Journal of the National Cancer Institute

Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC

Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy.

AJR. American journal of roentgenology

Lang P, Grampp S, Vahlensieck M, Johnston JO, Honda G, Rosenau W, Matthay KK, Peterfy C, Higgins CB, Genant HK

p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.

Cancer

Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechle-Schwarz M, Göppinger A, Pfleiderer A

Neuroblastoma: a clinical challenge and biologic puzzle.

CA: a cancer journal for clinicians

Matthay KK

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Villablanca JG, Khan AA, Avramis VI, Seeger RC, Matthay KK, Ramsay NK, Reynolds CP

Hematology and oncology.

Current opinion in pediatrics

Mentzer WC, Matthay K

Radiological case of the month. Miliary pulmonary neuroblastoma.

Archives of pediatrics & adolescent medicine

Kalra R, Zoger S, Kosovich MS, Matthay KK

Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.

European journal of cancer (Oxford, England : 1990)

Matthay KK, O'Leary MC, Ramsay NK, Villablanca J, Reynolds CP, Atkinson JB, Haase GM, Stram DO, Seeger RC

Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary MC, Harris RE, Selch M, Atkinson JB, Haase GM, Ramsay NK

Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans.

Clinical nuclear medicine

Hattner RS, Pounds TR, Matthay KK

Hematology and oncology.

Current opinion in pediatrics

Mentzer WC, Matthay K

Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.

Progress in clinical and biological research

Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary M, Harris RE, Selch M, Atkinson JB, Haase G, Hammond GD

Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.

Progress in clinical and biological research

Stram DO, Matthay KK, O'Leary M, Reynolds CP, Seeger RC

Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Parisi MT, Hattner RS, Matthay KK, Berg BO, Sandler ED

Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Atkinson JB, Stram DO, Selch M, Reynolds CP, Seeger RC

Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Campbell LA, Seeger RC, Harris RE, Villablanca JG, Matthay KK

Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.

Radiology

Parisi MT, Matthay KK, Huberty JP, Hattner RS

Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.

Proceedings of the National Academy of Sciences of the United States of America

Iavarone A, Matthay KK, Steinkirchner TM, Israel MA

Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes.

Biochimica et biophysica acta

Woodle MC, Matthay KK, Newman MS, Hidayat JE, Collins LR, Redemann C, Martin FJ, Papahadjopoulos D

Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia.

International journal of radiation oncology, biology, physics

Halberg FE, Kramer JH, Moore IM, Wara WM, Matthay KK, Ablin AR

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Proceedings of the National Academy of Sciences of the United States of America

Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C

Role of radiotherapy in neuroblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

D'Angio GJ, Matthay KK, Evans AE

An overview on the treatment of neuroblastoma.

Journal of nuclear biology and medicine (Turin, Italy : 1991)

Matthay KK

Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.

Journal of nuclear biology and medicine (Turin, Italy : 1991)

Matthay KK, Huberty JP, Hattner RS, Ablin AR, Engelstad BL, Zoger S, Hasegawa BH, Price D

Solid tumors in children.

The New England journal of medicine

D'Angio GJ, Matthay KK

Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.

Progress in clinical and biological research

Seeger RC, Villablanca JG, Matthay KK, Harris R, Moss TJ, Feig SA, Selch M, Ramsay N, Reynolds CP

Response of neuroblastoma to retinoic acid in vitro and in vivo.

Progress in clinical and biological research

Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB, Seeger RC

Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Halberg FE, Wara WM, Weaver KE, Wara DW, Ablin AR, Matthay KK, Mentzer WC, O'Leary MC, Cowan MJ

Hematologic disorders affecting the lungs.

Clinics in chest medicine

Edwards JR, Matthay KK

Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells.

Cancer research

Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D, Straubinger RM

Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD

Ewing's sarcoma of the mandible.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Langman AW, Kaplan MJ, Matthay K

Childhood acute lymphoblastic leukemia.

Pediatric annals

Diamond CA, Matthay KK

Patient, parent, and physician perspectives on pediatric oncology rounds.

The Journal of pediatrics

Lewis C, Knopf D, Chastain-Lorber K, Ablin A, Zoger S, Matthay K, Glasser M, Pantell R

Haploidentical bone marrow transplantation using soybean agglutinin-processed, T-depleted marrow.

Transplantation proceedings

Matthay K, Wara DW, Ablin AJ, Cowan MJ

Lymphocyte reconstitution in children receiving soybean agglutinin T-depleted bone marrow transplants.

Transplantation proceedings

Cowan MJ, McHugh T, Smith W, Wara D, Matthay K, Ablin A, Casavant C, Stites D

Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery.

Cancer research

Matthay KK, Heath TD, Badger CC, Bernstein ID, Papahadjopoulos D

Bone marrow in children with acute lymphocytic leukemia: MR relaxation times.

Radiology

Moore SG, Gooding CA, Brasch RC, Ehman RL, Ringertz HG, Ablin AR, Matthay KK, Zoger S

New methodology for liposome targeting to specific cells.

Annals of the New York Academy of Sciences

Papahadjopoulos D, Heath T, Bragman K, Matthay K

Spinal cord compression in a child with acute lymphoblastic leukemia.

The American journal of pediatric hematology/oncology

Lo WD, Matthay KK, Kushner J

Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.

The Journal of pediatrics

Weintrub PS, Schiffman G, Addiego JE, Matthay KK, Vichinsky E, Johnson R, Lubin B, Mentzer WC, Ammann AJ

Antibody-directed liposomes: the development of a cell-specific cytotoxic agent.

Biochemical Society transactions

Heath TD, Bragman KS, Matthay KK, Lopez-Straubinger NG, Papahadjopoulos D

Prenatal diagnosis of chronic granulomatous disease.

American journal of medical genetics

Matthay KK, Golbus MS, Wara DW, Mentzer WC

Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization.

The Journal of pediatrics

Chudwin DS, Wara DW, Matthay KK, Caulfield MH, Schiffmann G, Mentzer WC, Ammann AJ

Erythrocyte enzymopathies in the newborn.

Clinics in haematology

Matthay KK, Mentzer WC

Modification of hemoglobin H disease by sickle trait.

The Journal of clinical investigation

Matthay KK, Mentzer WC, Dozy AM, Kan YW, Bainton DF

Intracranial hemorrhage in congenital factor VII deficiency.

The Journal of pediatrics

Matthay KK, Koerper MA, Ablin AR